Adimmune Corp (4142):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Adimmune Corp (4142) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C7948
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:17
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:台湾
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Adimmune Corp (Adimmune) is a biopharmaceutical company that manufactures diagnostics, vaccines, and biological products for various diseases. The corporation’s products include tetanus toxoid adsorbed vaccine, influenza vaccine, Japan encephalitis vaccine, and ah1n1 vaccine. It also provides therapeutic nucleic acids, influenza vaccine, entrovirus 71 vaccine, and Japanese encephalitis vaccine. Adimmune offers such as seasonal flu vaccine plant, testing and analysis services, fill and finish services, quality assurance courses, and consulting services. The corporation offers product testing and analysis of quality of vaccines and biological products, and also offers other relevant testing services. It sells products through a network of distributors in Taiwan. Adimmune is headquartered in Taichung, Taiwan.

Adimmune Corp (4142) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Adimmune Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Adimmune Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Adimmune Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Adimmune Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Adimmune Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Adimmune Corp, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Hualan Biological Engineering To Enter Into R&D Agreement With Adimmune 10
Licensing Agreements 11
Valneva Enters into Licensing Agreement with Adimmune for Japanese Encephalitis Vaccine 11
Adimmune Enters into Licensing Agreement with National Health Research 12
Debt Offering 13
Adimmune Raises USD47.5 Million in Private Placement of Bonds Due 2021 13
Adimmune Corp – Key Competitors 14
Adimmune Corp – Key Employees 15
Adimmune Corp – Locations And Subsidiaries 16
Head Office 16
Appendix 17
Methodology 17
About GlobalData 17
Contact Us 17
Disclaimer 17

List of Tables
Adimmune Corp, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Adimmune Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Adimmune Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Adimmune Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Adimmune Corp, Deals By Therapy Area, 2012 to YTD 2018 8
Adimmune Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Hualan Biological Engineering To Enter Into R&D Agreement With Adimmune 10
Valneva Enters into Licensing Agreement with Adimmune for Japanese Encephalitis Vaccine 11
Adimmune Enters into Licensing Agreement with National Health Research 12
Adimmune Raises USD47.5 Million in Private Placement of Bonds Due 2021 13
Adimmune Corp, Key Competitors 14
Adimmune Corp, Key Employees 15

List of Figures
Adimmune Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Adimmune Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Adimmune Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Adimmune Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Adimmune Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Adimmune Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Adimmune Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Adimmune Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Adimmune Corp (4142):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • SATT South East SAS:製薬・医療:M&Aディール及び事業提携情報
    Summary SATT South East SAS (SATT South East), formerly Satt Paca Corse SAS, a subsidiary of SATT Association, is a business and consumer services company that offers technology transfer services. The company offers invention disclosure, intellectual property management, economic market, technology …
  • Christian Dior SE:企業の戦略・SWOT・財務情報
    Christian Dior SE - Strategy, SWOT and Corporate Finance Report Summary Christian Dior SE - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Anixter International Inc (AXE):電力:M&Aディール及び事業提携情報
    Summary Anixter International Inc. (Anixter), formerly Itel Corporation, is a distributor of network and security solutions, electrical and electronic solutions and utility power solutions. The company distributes communications, and electrical wire and cable products, fasteners and C Class inventor …
  • BillerudKorsnas AB:企業の戦略・SWOT・財務情報
    BillerudKorsnas AB - Strategy, SWOT and Corporate Finance Report Summary BillerudKorsnas AB - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Avacta Group Plc (AVCT):企業の財務・戦略的SWOT分析
    Summary Avacta Group Plc (Avacta) is a developer therapeutic molecules used in a wide range of life sciences applications in research and diagnostics. The company offers products that include optim and sensipod. It also develops UCB celltech that is an analytical instrument. Avacta’s sensipod is an …
  • Medshape Inc:医療機器:M&Aディール及び事業提携情報
    Summary Medshape Inc (MedShape), formerly MedShape Solutions Inc, is a medical device company that develops and manufactures orthopedic devices for the orthopedic healthcare markets. The company provides products such as dynanail ankle arthrodesis nail, eclipse soft tissue anchor, exoshape teno soft …
  • SRT Marine Systems plc (SRT):企業の財務・戦略的SWOT分析
    SRT Marine Systems plc (SRT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • United Services Automobile Association:企業のM&A・事業提携・投資動向
    United Services Automobile Association - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's United Services Automobile Association Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed repo …
  • Kinross Gold Corp:企業の戦略・SWOT・財務情報
    Kinross Gold Corp - Strategy, SWOT and Corporate Finance Report Summary Kinross Gold Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Panoro Energy ASA (PEN):企業の財務・戦略的SWOT分析
    Summary Panoro Energy ASA (Panoro) is an independent oil and gas exploration and development company that explores, develops and produces oil and gas properties in Brazil and West Africa. The company holds interests in production and exploration assets in Santos and Camamu Almada basins in Brazil. I …
  • Church & Dwight Co Inc:企業のM&A・事業提携・投資動向
    Church & Dwight Co Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Church & Dwight Co Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions …
  • Okinawa Electric Power Company Incorporated:発電所・企業SWOT分析
    Okinawa Electric Power Company Incorporated – Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, info …
  • Lotte Chemical Corp (011170):企業の財務・戦略的SWOT分析
    Lotte Chemical Corp (011170) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Translate Bio Inc (TBIO):製薬・医療:M&Aディール及び事業提携情報
    Summary Translate Bio Inc (Translate Bio), formerly RaNA Therapeutics Inc is a healthcare service provider that develops therapies which targets RNA within cells in the body to selectively activate protein expression. The company provides platform oligonucleotides (oligos) are molecules designed to …
  • Clean Harbors Inc (CLH):石油・ガス:M&Aディール及び事業提携情報
    Summary Clean Harbors Inc (Clean Harbors) is a provider of environmental, industrial and energy services. The company offers waste disposal and recycling, emergency response, chemical packing, field services, production services, exploration services, directional boring, lodging services and onsite …
  • Loews Corp:企業の戦略・SWOT・財務情報
    Loews Corp - Strategy, SWOT and Corporate Finance Report Summary Loews Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • HSBC Seguros de Vida Argentina S.A.:企業の戦略・SWOT・財務情報
    HSBC Seguros de Vida Argentina S.A. - Strategy, SWOT and Corporate Finance Report Summary HSBC Seguros de Vida Argentina S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, …
  • Origin Energy Ltd (ORG)-エネルギー分野:企業M&A・提携分析
    Summary Origin Energy Limited (Origin Energy) is an integrated energy company. It generates, supplies and distributes electricity; explores and develops natural gas reserves; and produces and sells gas. The company generates electricity from natural-gas fired, coal-fired, wind, solar, pumped water s …
  • MRI Interventions Inc (MRIC)-医療機器分野:企業M&A・提携分析
    Summary MRI Interventions Inc (MRI Interventions) is a medical device company that develops and commercializes platforms for performing invasive surgical procedures. The company’s product platforms include clearpoint system, which is used for minimally invasive surgical procedures in the brain; and …
  • Albéa Beauty Holdings S.A.:企業の戦略・SWOT・財務情報
    Albéa Beauty Holdings S.A. - Strategy, SWOT and Corporate Finance Report Summary Albéa Beauty Holdings S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆